NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP China Pharmas » Simcere Pharmaceutical Group  «  1  2    
found files: 23
Simcere Pharmaceutical Group »05/04/2010 [Company watch]
Operations of Simceres Latest Acquisition Remain Shut Down

Simcere Pharmaceutical Group reported that a recent acquisition, Jiangsu Yanshen Biological Technology, committed fraud with respect to its human-use rabies vaccine. Simcere bought a controlling interest in Jiangsu Yanshen in October 2009 and shut down its operations just one month later. As soon as Simcere found out about the problem, it urged Jiangsu Yanshen’s board to cease operations and review the company s quality control....   more»

Simcere Pharmaceutical Group »22/04/2010 [Company watch]
Simcere Pharma Moves Closer to International Sales with Approval for Diarrhea Drug

Simcere Pharma (NYSE: SCR) reported that diosmectite, the API in its branded generic diarrhea drug Biqi, has passed EU-GMP inspection. Diosmectite is made from a natural mineral, and Simcere owns a high-grade diosmectite mine in China. It is the leading anti-diarrhea drug in China and France....   more»

Simcere Pharmaceutical Group »17/05/2010 [Company watch]
Simcere Wants to Sell OTC Division, Add Prescription Drug Partnerships

...   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.